Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ionis Pharmaceuticals (IONS)
Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,097,560
  • Shares Outstanding, K 143,472
  • Annual Sales, $ 587,370 K
  • Annual Income, $ -269,720 K
  • 60-Month Beta 0.46
  • Price/Sales 12.08
  • Price/Cash Flow N/A
  • Price/Book 21.99
Trade IONS with:

Options Overview Details

View History
  • Implied Volatility 34.11% ( +0.56%)
  • Historical Volatility 40.64%
  • IV Percentile 37%
  • IV Rank 23.59%
  • IV High 52.54% on 02/24/23
  • IV Low 28.42% on 09/01/23
  • Put/Call Vol Ratio 1.69
  • Today's Volume 1,545
  • Volume Avg (30-Day) 694
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 18,627
  • Open Int (30-Day) 17,804

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.99
  • Number of Estimates 11
  • High Estimate -0.55
  • Low Estimate -1.31
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -167.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.43 +18.88%
on 11/02/23
51.89 -0.50%
on 12/01/23
+6.37 (+14.07%)
since 11/01/23
3-Month
39.08 +32.11%
on 09/06/23
51.89 -0.50%
on 12/01/23
+11.13 (+27.48%)
since 09/01/23
52-Week
32.69 +57.94%
on 03/15/23
51.89 -0.50%
on 12/01/23
+11.43 (+28.43%)
since 12/01/22

Most Recent Stories

More News
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 51.63 (+4.37%)
Ionis to hold third quarter 2023 financial results webcast

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, November 2nd at 11:30 a.m. Eastern...

IONS : 51.63 (+4.37%)
Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercialization

With experienced commercial team in place, Ionis poised to independently bring steady cadence of potentially transformational RNA-targeted medicines to...

IONS : 51.63 (+4.37%)
Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that The Journal of the American Medical Association (JAMA) published positive...

IONS : 51.63 (+4.37%)
Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's disease

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered an agreement with Roche for two undisclosed early-stage programs...

IONS : 51.63 (+4.37%)
Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome

Olezarsen met the primary endpoint with a statistically significant reduction in triglyceride levels versus placebo First study to show an absolute reduction...

IONS : 51.63 (+4.37%)
Ionis to host investor and analyst day event

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host an investor and analyst day on Wednesday, October 4. The event...

IONS : 51.63 (+4.37%)
Ionis to present at upcoming investor conferences

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor...

IONS : 51.63 (+4.37%)
Ionis Pharmaceuticals: Q2 Earnings Snapshot

Ionis Pharmaceuticals: Q2 Earnings Snapshot

IONS : 51.63 (+4.37%)
Ionis reports second quarter 2023 financial results

/PRNewswire/ -- – Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the "Company"), today reported financial results for the second quarter of 2023. Financial...

IONS : 51.63 (+4.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

See More

Key Turning Points

3rd Resistance Point 55.97
2nd Resistance Point 53.93
1st Resistance Point 52.78
Last Price 51.63
1st Support Level 49.59
2nd Support Level 47.55
3rd Support Level 46.40

See More

52-Week High 51.89
Last Price 51.63
Fibonacci 61.8% 44.56
Fibonacci 50% 42.29
Fibonacci 38.2% 40.02
52-Week Low 32.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar